Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade.

[1]  I. Pinchuk,et al.  Disruption of retinol-mediated IL-6 expression in colon cancer-associated fibroblasts: new perspectives on the role of vitamin A metabolism , 2023, Oncotarget.

[2]  A. Weeraratna,et al.  Fibroblasts in cancer: Unity in heterogeneity , 2023, Cell.

[3]  M. Kano,et al.  Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment , 2023, Cancers.

[4]  J. Elstrott,et al.  LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity , 2022, Nature.

[5]  W. Li,et al.  Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy. , 2022, Cytokine & growth factor reviews.

[6]  A. Sakai,et al.  Good and Bad Stroma in Pancreatic Cancer: Relevance of Functional States of Cancer-Associated Fibroblasts , 2022, Cancers.

[7]  R. Kalluri,et al.  Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer. , 2022, Cancer cell.

[8]  A. Cameron,et al.  Cancer‐associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets , 2022, The Journal of pathology.

[9]  H. Haga,et al.  Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics , 2022, Oncogene.

[10]  N. Asai,et al.  A novel renal perivascular mesenchymal cell subset gives rise to fibroblasts distinct from classic myofibroblasts , 2022, Scientific Reports.

[11]  N. Asai,et al.  Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade , 2022, Life Science Alliance.

[12]  A. Enomoto,et al.  Safety and efficacy of MIKE-1 in patients with advanced pancreatic cancer: a study protocol for an open-label phase I/II investigator-initiated clinical trial based on a drug repositioning approach that reprograms the tumour stroma , 2022, BMC Cancer.

[13]  N. Asai,et al.  Roles of the Mesenchymal Stromal/Stem Cell Marker Meflin/Islr in Cancer Fibrosis , 2021, Frontiers in Cell and Developmental Biology.

[14]  R. Kalluri,et al.  Clinical and therapeutic relevance of cancer-associated fibroblasts , 2021, Nature Reviews Clinical Oncology.

[15]  Masahide Takahashi,et al.  Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis , 2021, European Respiratory Journal.

[16]  F. Mechta-Grigoriou,et al.  Role of cancer‐associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer , 2021, Immunological reviews.

[17]  S. Turley,et al.  Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer. , 2021, Immunity.

[18]  N. Asai,et al.  Meflin defines mesenchymal stem cells and/or their early progenitors with multilineage differentiation capacity , 2021, Genes to cells : devoted to molecular & cellular mechanisms.

[19]  R. Kalluri,et al.  Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer. , 2021, Cancer cell.

[20]  J. Hasty,et al.  The balance of stromal BMP signaling mediated by GREM1 and ISLR drives colorectal carcinogenesis. , 2020, Gastroenterology.

[21]  M. Xiong,et al.  Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma , 2020, Nature Communications.

[22]  D. Tuveson,et al.  DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS. , 2020, Physiological reviews.

[23]  A. Maitra,et al.  Recent insights into the biology of pancreatic cancer , 2020, EBioMedicine.

[24]  Masahide Takahashi,et al.  Cancer‐associated fibroblasts that restrain cancer progression: Hypotheses and perspectives , 2020, Cancer science.

[25]  K. Goralski,et al.  More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer , 2019, International journal of molecular sciences.

[26]  Yun-Gui Yang,et al.  Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma , 2019, Cell Research.

[27]  V. Balachandran,et al.  Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities. , 2019, Gastroenterology.

[28]  Masahide Takahashi,et al.  Cancer-associated fibroblasts in gastrointestinal cancer , 2019, Nature Reviews Gastroenterology & Hepatology.

[29]  Masahide Takahashi,et al.  Chemerin promotes angiogenesis in vivo , 2018, Physiological reports.

[30]  T. Tsukamoto,et al.  Established gastric cancer cell lines transplantable into C57BL/6 mice show fibroblast growth factor receptor 4 promotion of tumor growth , 2018, Cancer science.

[31]  D. Tuveson,et al.  Br Ief Definitive Repor T , 2022 .

[32]  M. Takeya,et al.  CAFs and TAMs: maestros of the tumour microenvironment , 2017, The Journal of pathology.

[33]  R. Kalluri.  The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[34]  N. Asai,et al.  Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells , 2016, Scientific Reports.

[35]  K. Shudo,et al.  Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells. , 2016, The Journal of investigative dermatology.

[36]  E. Wherry,et al.  Molecular and cellular insights into T cell exhaustion , 2015, Nature Reviews Immunology.

[37]  G. Wahl,et al.  Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy , 2014, Cell.

[38]  J. Rourke,et al.  Towards an integrative approach to understanding the role of chemerin in human health and disease , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[39]  A. Sato,et al.  The effect of synthetic retinoid, Am80, on T helper cell development and antibody production in murine collagen-induced arthritis , 2010, Modern rheumatology.

[40]  R. Yoshimoto,et al.  Identification of a stable chemerin analog with potent activity toward ChemR23 , 2009, Peptides.

[41]  T. Yamamura,et al.  Synthetic retinoid AM80 inhibits Th17 cells and ameliorates experimental autoimmune encephalomyelitis. , 2009, The American journal of pathology.

[42]  Y. Hashimoto,et al.  Expression of retinoic acid receptor genes and the ligand-binding selectivity of retinoic acid receptors (RAR's). , 1990, Biochemical and biophysical research communications.